Brief: Syneos Health Announces Partnership With Fosun Pharma USA To Launch Serplulimab
11/01/2023 12:38
Jan 11 (Reuters) - Shanghai Fosun Pharmaceutical Group
Co Ltd 600196.SS :
* SYNEOS HEALTH ANNOUNCES PARTNERSHIP WITH FOSUN PHARMA USA
TO
LAUNCH SERPLULIMAB
* SYNEOS HEALTH INC - AS PART OF PARTNERSHIP, CO WILL
PROVIDE
FULL-SERVICE COMMERCIAL SUPPORT THROUGH ITS SYNEOS ONE® TEAM FOR
LAUNCH OF SERPLULIMAB
Source text for Eikon: ID:nGNX52hlzW
Further company coverage: 600196.SS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Syneos Health
See all newsHayward Holdings rises on S&P Smallcap 600 inclusion
Brief: Syneos Health And Oracle To Expand Partnership
Large LBO bond sales could prompt September US junk debt rush
Brief: SYNEOS HEALTH AND STAR PARENT ANNOUNCE PROPOSED $1.70 BILLION OFFERING OF SENIOR SECURED NOTES
Brief: Syneos Health Announces Agreement With Aotearoa Clinical Trials, Expanding Clinical Trial Capabilities Across Range Of Therapeutic Areas In New Zealand